National Taiwan University
Taiwan Regulators Clear Phase I Trial for Eden BioCell's Autologous CAR T-Cell Leukemia Treatment
Researchers aim to evaluate the safety and tolerability of the CD19-specific T cells manufactured using Ziopharm's Rapid Personalized Manufacturing process.